Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine - Concepedia

Concepedia

Publication | Closed Access

Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine

168

Citations

24

References

2007

Year

Jiangtao Lin, Jiansan Zhang, Nan Su, Jianguo Xu, Nan Wang, Jiang-Ting Chen, Xin Chen, Yuxuan Liu, Hong Gao, Yuping Jia,

Antiviral Therapy

Abstract

The inactivated vaccine was safe and well tolerated and can elicit SARS-CoV-specific neutralizing antibodies.

References

	Year	Citations

Page 1